Profusa Inc PFSA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.69
- Day Range
- $1.61–1.72
- 52-Week Range
- $1.58–3,000.00
- Bid/Ask
- $1.69 / $1.71
- Shares Outstanding
- 605,647.00
- Market Cap
- $1.02M
- Volume/Avg
- 86,994 / 3M
Key Statistics
- Price/Earnings (Normalized)
- 0.00
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.profusa.com
Valuation
|
Metric
|
PFSA
|
|---|---|
Price/Earnings (Normalized) | 0.00 |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PFSA
Financial Strength
|
Metric
|
PFSA
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
Interest Coverage | −183.42 |
Quick Ratio
PFSA
Profitability
|
Metric
|
PFSA
|
|---|---|
Return on Assets (Normalized) | −1,791.59% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PFSA
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|^%bkvC | LOCK|NBd> | $169B | |||
| Medtronic PLC
MDT
| LOCK|s>!&y#$ | LOCK|Z^P#v | $110B | |||
| Stryker Corp
SYK
| LOCK|D@M!!&# | LOCK|XG? | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|ghg?fd> | LOCK|lSLj | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&T>mzj%B | LOCK|NH#%r | $49B | |||
| DexCom Inc
DXCM
| LOCK|$sY>Kk$ | LOCK|GCt!n | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|T^#p$^k | LOCK|t% | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|@? | LOCK|!Y | $23B | |||
| Steris PLC
STE
| LOCK|@@?@bJ | LOCK|&V&d | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|%>f#$Nq | LOCK|Yw | $17B |
United States